SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

MOLBIO (MOLBIO) News

Follow MOLBIO (MOLBIO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 12 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol MOLBIO Asset market Sector Markets 90 days 12 Updated Oct 01, 2026, 07:52 AM UTC Open live news feed
M Molbio Diagnostics Shares Jump 5% on HDFC MF Stake Acquisition Molbio Diagnostics' share price surged over 5% on Thursday, October 1, driven by a bulk deal transaction where HDFC Mutual Fund acquired a 1.99% stake, representing 23 lakh shares, on September 30. The company's stock is EQUITY | Oct 01, 2026, 07:52 AM UTC L Indian shares inch higher after recent slide; IT stocks lead By Bharath Rajeswaran and Vivek Kumar MIndian shares were marginally up on Wednesday after a two-day selloff from persistent foreign selling and elevated oil prices.Brent crude futures ICEEUR:BRN1! were up 0.5% to $103.1 COMMODITIES | Sep 30, 2026, 05:15 AM UTC L Jefferies's top stock recommendation: Buy rating with 27% upside | Indian share up 57% against IPO price in one month New Delhi, Sept. 30 -- Jefferies stock recommendations | Indian stock market: Molbio Diagnostics IPO is one of those rare Indian IPOs that have delivered a whopping return to its share allottees. The public issue was ava EQUITY | Sep 30, 2026, 04:53 AM UTC H Indian shares struggle for direction after two-day selloff By Bharath Rajeswaran and Vivek Kumar MIndian shares were muted on Wednesday as a rebound in most sectors after a two-day selloff offset sustained foreign selling and a rise in oil prices driven by the absence of a US-Ir COMMODITIES | Sep 30, 2026, 04:35 AM UTC L India tech funding rises 7% to $10.3 billion in 9M 2026 India’s tech companies raised a combined $10.3B in the first nine months of 2026 marking a 7 per cent increase over the $9.7B raised in the same period a year earlier, and 3 per cent above the $10B raised in 9M 2024, acc NEWS | Sep 24, 2026, 03:15 PM UTC L HDFC MF Sells 1.45% Stake In Escorts Kubota For Rs 453 Cr Nippon India Mutual Fund acquired 12.94 lakh Escorts Kubota shares, representing a 1.16 per cent stake, for Rs 361.69 croreHDFC Mutual Fund (MF) sold a 1.45 per cent stake in agriculture and engineering company Escorts K EQUITY | Sep 24, 2026, 02:02 PM UTC L Tech Sector Sees More Capital With Fewer Deals In 9M 2026 Funding rose despite a 38 per cent drop in deal volume, with AI infrastructure, enterprise technology and fintech drawing larger roundsTechnology companies raised USD 10.3 billion in the first nine months of 2026, up 7 p NEWS | Sep 24, 2026, 08:01 AM UTC M Molbio Diagnostics slips after sharp post-rally reversal Molbio Diagnostics, recently listed, fell as investors booked profits following a strong earlier run, reversing sharply on Sept. 16. EQUITY | Sep 16, 2026, 07:33 AM UTC L Markets Espresso: That 80s newsletter; aala re aala, NSE IPO aala Namashkar. Aap padh rahe hai Markets Espresso ka naya adhyay! Pesh hai, is hafte ki tamaam surkhiyaan! Back to Doordarshan? Hehe. Instagram has hopped on to a new trend - a throwback to the 80s, so we thought: how about EQUITY | Sep 12, 2026, 05:32 AM UTC L Molbio Diagnostics stock locked at 20% upper circuit; IPO jump 87% Molbio Diagnostics shares were locked in a 20% upper circuit on Thursday, 10 September. The stock, listed on 17 August 2026, has surged nearly 87% from its IPO price of Rs.807 per share and reached an all-time high. EQUITY | Sep 10, 2026, 10:02 AM UTC L Molbio Diagnostics stock hits 20% upper circuit at ₹1,509.40 Molbio Diagnostics Ltd. shares were locked in a 20% upper circuit at ₹1,509.40 on Thursday, September 10. The stock is up around 87% from its IPO price of ₹807 and has extended gains from its issue price. EQUITY | Sep 10, 2026, 07:43 AM UTC L Molbio Diagnostics down 2% even after Q2 profit reported Molbio Diagnostics shares fell 2% after reporting consolidated profit of ₹58.7 crore in Q2 versus a ₹23.7 crore loss in the year-ago period. EARNINGS | Sep 07, 2026, 04:26 AM UTC